Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
NEW YORK, March 08, 2016 -- Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Chris Pasquale will join the equity research department as a Director covering the Medical Supplies and Devices sector. He will commence work at Guggenheim in April.
Mr. Pasquale will be coming to Guggenheim from J.P. Morgan, where he worked on the top-ranked medical supplies and devices team, according to the Institutional Investor Magazine 2015 Rankings.
“We are excited to have Chris on our Healthcare team,” said John Hervey, Director of Research at Guggenheim Securities. “His company coverage brings an important new dimension to our Healthcare coverage; strengthens the outstanding fundamental research team of Tony Butler, Louise Chen, and Bill Tanner; as well as complements the outstanding policy research that we produce through our Washington Research Group.”
Mr. Pasquale earned his B.S. at Duke University. He will operate out of Philadelphia, where he resides.
About Guggenheim Securities
Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers a full range of services that fall into four broad categories: Advisory, Sales and Trading, Financing, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Atlanta, Boston, Chicago, Los Angeles, and San Francisco. For more information, visit guggenheimpartners.com.
About Guggenheim Partners
Guggenheim Partners is a global investment and advisory firm with more than $240 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.
1Assets under management are as of 12.31.2015 and include consulting services for clients whose assets are valued at approximately $47bn.
Media Contact Ellen Cunningham Guggenheim Partners 212.518.9578 [email protected]
